However, based on published reports, LINC00519 and THAP7-AS1 may become potential drug targets and biomarkers for CCA, and the three key networks in which they are involved may be able to explain the occurrence and progress of CCA. This evidence concerns the gene THAP7 and cholangiocarcinoma.